Rhode Islands governor also has proposed removing GLP-1 coverage from the states Medicaid program for weight loss treatment
The state still covers GLP-1s for diabetes and certain other conditions
Lower appetite often means less salt and calories, affecting thermoregulation
For 40+ years, my work and that of others supported the view that addiction is a disorder of maladaptive dopaminergic learning
Post-cycle therapy considerations arise when Testosterone use extends beyond temporary research periods
The following table breaks down key characteristics of various GLP-1 RAs, including Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, Saxenda, and Victoza, to give a clearer picture of their differences: This table elucidates the Ozempic vs Mounjaro debate, showing Mounjaros unique position with very high efficacy in both weight loss and blood sugar control